Homo sapiens Protein: PNPLA6
Summary
InnateDB Protein IDBP-368381.5
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol PNPLA6
Protein Name patatin-like phospholipase domain containing 6
Synonyms BNHS; iPLA2delta; NTE; NTEMND; SPG39; sws;
Species Homo sapiens
Ensembl Protein ENSP00000394348
InnateDB Gene IDBG-22916 (PNPLA6)
Protein Structure
UniProt Annotation
Function Phospholipase B that deacylates intracellular phosphatidylcholine (PtdCho), generating glycerophosphocholine (GroPtdCho). This deacylation occurs at both sn-2 and sn-1 positions of PtdCho. Its specific chemical modification by certain organophosphorus (OP) compounds leads to distal axonopathy. {ECO:0000269PubMed:15044461, ECO:0000269PubMed:1666291}.
Subcellular Localization Endoplasmic reticulum membrane {ECO:0000269PubMed:15044461}; Single-pass type I membrane protein {ECO:0000269PubMed:15044461}; Cytoplasmic side {ECO:0000269PubMed:15044461}. Note=Anchored to the cytoplasmic face of the endoplasmic reticulum by its amino-terminal transmembrane segment.
Disease Associations Spastic paraplegia 39, autosomal recessive (SPG39) [MIM:612020]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG39 is associated with a motor axonopathy affecting upper and lower limbs and resulting in progressive wasting of distal upper and lower extremity muscles. {ECO:0000269PubMed:18313024, ECO:0000269PubMed:24355708}. Note=The disease is caused by mutations affecting the gene represented in this entry.Boucher-Neuhauser syndrome (BNHS) [MIM:215470]: An autosomal recessive disorder characterized by spinocerebellar ataxia, hypogonadotropic hypogonadism, and visual impairment due to chorioretinal dystrophy. The age at onset is variable, but most patients develop 1 or more symptoms in the first decade of life. Chorioretinal dystrophy may not always be present. {ECO:0000269PubMed:24355708}. Note=The disease is caused by mutations affecting the gene represented in this entry.
Tissue Specificity Expressed in brain, placenta, kidney, neuron and skeletal muscle. {ECO:0000269PubMed:9576844}.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 5 experimentally validated interaction(s) in this database.
Experimentally validated
Total 5 [view]
Protein-Protein 4 [view]
Protein-DNA 1 [view]
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Gene Ontology

Molecular Function
Accession GO Term
GO:0004622 lysophospholipase activity
Biological Process
GO:0006629 lipid metabolic process
GO:0008152 metabolic process
GO:0008219 cell death
GO:0016042 lipid catabolic process
GO:0046470 phosphatidylcholine metabolic process
Cellular Component
GO:0005789 endoplasmic reticulum membrane
GO:0016020 membrane
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID
InterPro IPR000595 Cyclic nucleotide-binding domain
IPR002641 Patatin/Phospholipase A2-related
IPR016035 Acyl transferase/acyl hydrolase/lysophospholipase
IPR018490 Cyclic nucleotide-binding-like
PFAM PF00027
PF01734
PRINTS
PIRSF
SMART SM00100
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q8IY17
PhosphoSite PhosphoSite-Q8IY17
TrEMBL M0R2K2
UniProt Splice Variant
Entrez Gene 10908
UniGene Hs.631863
RefSeq NP_001159585
HUGO HGNC:16268
OMIM 603197
CCDS CCDS32891
HPRD 04432
IMGT
EMBL AC008878 AC009003 AJ004832 AK294021 AK302462 AL050362 BC038229 BC050553 BC051768 CH471139
GenPept AAH38229 AAH50553 AAH51768 BAG57380 BAH13718 CAA06164 CAB43674 EAW69029